Last updated 2026-06-18
- Raised funding round, Oct 2016
Total raised
—
Last: 2016-10
Stage
Seed
Founded
2011
Headcount
6
HQ
Ramat Gan, Israel
Sector
Health Tech & Life Sciences
About
I2O Pharma specializes in developing oral versions of injectable drugs, using technology licensed from the Hebrew University of Jerusalem. The company is now planning human trials. I2O Pharma is supported byAurum Ventures MKI. The company is inactive and the updating process will be stopped since 11/2018.
Funding history · 1 round · — total
2016-10
Undisclosed
Q&A
- What is I2O Pharma's primary focus?
- I2O Pharma specializes in developing oral versions of injectable drugs, utilizing technology licensed from the Hebrew University of Jerusalem.
- When was I2O Pharma founded?
- I2O Pharma was founded in December 2011.
- What is the current status of I2O Pharma?
- I2O Pharma is currently inactive, with its status changed in January 2018.
- How many employees does I2O Pharma have?
- I2O Pharma has 1-10 employees.
- Which investor supported I2O Pharma in its funding round?
- I2O Pharma was supported by Aurum Ventures M.K.I. in a funding round in October 2016.
- What is I2O Pharma's current product stage?
- I2O Pharma's product is in the clinical trial stage, with plans for human trials.
- Who is the founder of I2O Pharma?
- Dan Gelvan is the Founder, CEO, and Chairman of I2O Pharma.
- Where is I2O Pharma's headquarters located?
- I2O Pharma's headquarters is located in Ramat Gan, Center District, Israel.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
pharmaceuticalsdrug-deliveryoral-drugspharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2011-12 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Jan 2018 |